Understanding genetic factors in aggressive prostate cancer
Cancer Detection & Diagnosis Research-2022-Comprehensive genomic profiling of aggressive hormone sensitive prostate cancer
This study is looking at the genes in tumor samples from men with aggressive hormone-sensitive prostate cancer to find clues that can help predict how well they will respond to treatment, with the hope of creating more personalized care for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Adelaide NIH-funded |
| Lab location | 1 site (Adelaide, Australia) |
| Project ID | NIH-10926904 on NIH RePORTER |
What this research studies
This research investigates the genetic profiles of tumor samples from patients with aggressive hormone-sensitive prostate cancer to identify biomarkers that predict treatment responses. By analyzing samples from two major clinical trials, the study aims to uncover how mutations in specific tumor suppressor genes affect patient outcomes. The goal is to enhance the understanding of why some patients respond well to hormonal therapies while others do not, ultimately leading to more personalized treatment approaches. Patients involved in the trials have already contributed valuable data that will be analyzed over the next several years.
Who could benefit from this research
Good fit: Ideal candidates for this research are men diagnosed with metastatic hormone-sensitive prostate cancer who have participated in the referenced clinical trials.
Not a fit: Patients with non-aggressive prostate cancer or those who have not undergone hormonal therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies for patients with aggressive prostate cancer, potentially increasing survival rates.
How similar studies have performed: Previous research has shown promising results in identifying genetic markers that influence treatment responses in various cancers, suggesting that this approach could yield valuable insights.
Where this research is happening
Adelaide, Australia
- University of Adelaide — Adelaide, Australia (Active)
Researchers
- Principal investigator: Sweeney, Christopher J — University of Adelaide
- Study coordinator: Sweeney, Christopher J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.